Literature DB >> 15070571

Migraine.

Stephen D Silberstein1.   

Abstract

Migraine is a very common neurobiological headache disorder that is caused by increased excitability of the CNS. It ranks among the world's most disabling medical illnesses. Diagnosis is based on the headache's characteristics and associated symptoms. The economic and societal effect of migraine is substantial: it affects patients' quality of life and impairs work, social activities, and family life. There are many acute and preventive migraine treatments. Acute treatment is either specific (triptans and ergots) or non-specific (analgesics). Disabling migraine should be treated with triptans. Increased headache frequency is an indication for preventive treatment. Preventive treatment decreases migraine frequency and improves quality of life. More treatments are being developed, which provides hope to the many patients whose migraines remain uncontrolled.

Entities:  

Mesh:

Year:  2004        PMID: 15070571     DOI: 10.1016/S0140-6736(04)15440-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  80 in total

Review 1.  Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis.

Authors:  Pamela M Rist; Hans-Christoph Diener; Tobias Kurth; Markus Schürks
Journal:  Cephalalgia       Date:  2011-04-21       Impact factor: 6.292

Review 2.  Migraine and movement disorders.

Authors:  F d'Onofrio; P Barbanti; V Petretta; G Casucci; A Mazzeo; B Lecce; C Mundi; D Cologno
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 3.  The Insula: A "Hub of Activity" in Migraine.

Authors:  David Borsook; Rosanna Veggeberg; Nathalie Erpelding; Ronald Borra; Clas Linnman; Rami Burstein; Lino Becerra
Journal:  Neuroscientist       Date:  2015-08-19       Impact factor: 7.519

Review 4.  Tumour necrosis factor gene polymorphisms and migraine: a systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Robert Yl Zee; Daniel I Chasman; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-10       Impact factor: 6.292

Review 5.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 6.  Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Bahi Takkouche; Francisco Caamaño Isorna; Ali Samii
Journal:  BMJ       Date:  2004-12-13

7.  Saline pomphus around scalp arteries can block migraine pain.

Authors:  C Cianchetti; Y Hmaidan
Journal:  J Neurol       Date:  2007-11-16       Impact factor: 4.849

8.  Intercepting migraine: results of early therapy with nonspecific and migraine-specific agents.

Authors:  Robert Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2006-01       Impact factor: 3.598

Review 9.  Migraine and mortality: a systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Robert E Shapiro; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-07-29       Impact factor: 6.292

Review 10.  Migraine and cerebrovascular disease: still a dangerous connection?

Authors:  Elio Clemente Agostoni; Marco Longoni
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.